8-K: Lineage Cell Therapeutics Changes Independent Auditor, Appoints Moss Adams
8-K Filing
Lineage Cell Therapeutics has dismissed WithumSmith+Brown, PC and appointed Moss Adams LLP as its new independent registered public accounting firm, effective June 11, 2024.
Summary
- Lineage Cell Therapeutics has changed its independent registered public accounting firm.
- The company's Audit Committee approved the dismissal of WithumSmith+Brown, PC (Withum) on June 11, 2024.
- Withum had audited the company's financial statements for the years ended December 31, 2023 and 2022.
- Withum's audit report for 2023 and 2022 did not contain any adverse opinions, disclaimers, or qualifications.
- There were no disagreements or reportable events between Lineage and Withum during the two years ended December 31, 2023, and through June 11, 2024.
- The Audit Committee also approved the engagement of Moss Adams LLP as the new independent auditor, effective June 11, 2024.
- Lineage did not consult Moss Adams on accounting principles, audit opinions, or any matters that would have been subject to disagreement or reportable events prior to their engagement.
Sentiment
Score: 7
Explanation: The document indicates a routine change of auditors with no reported issues, suggesting a neutral to slightly positive sentiment.
Positives
- The transition to a new auditor was smooth, with no reported disagreements or issues with the previous auditor.
- Withum's audit reports for the past two years were clean, indicating no significant accounting or financial reporting concerns.
- The company has quickly engaged a new auditor, Moss Adams, ensuring continuity in financial oversight.
Risks
- The change in auditors could potentially raise questions from investors or stakeholders, although no issues were reported.
- There is a risk of disruption during the transition to the new auditor, although this is not explicitly mentioned.
Industry Context
Changes in auditors are not uncommon, but they can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting. In this case, there is no indication of any issues with the previous auditor.
Comparison to Industry Standards
- The change of auditors is a common practice in the industry, and the process followed by Lineage appears to be standard.
- Many companies switch auditors periodically to ensure independence and fresh perspectives.
- The lack of disagreements or reportable events with the previous auditor is a positive sign, as it indicates no major accounting or financial reporting issues.
Stakeholder Impact
- Shareholders may have questions about the change in auditors, but the lack of reported issues should be reassuring.
- Employees in the finance and accounting departments will need to work with the new auditor.
Key Dates
| Date | Description |
|---|---|
| December 31, 2022 | End of the fiscal year for which Withum audited the financial statements. |
| December 31, 2023 | End of the fiscal year for which Withum audited the financial statements. |
| March 7, 2024 | Date of Withum's audit report for the 2023 and 2022 financial statements. |
| June 11, 2024 | Date of dismissal of Withum and engagement of Moss Adams as the new auditor. |
| June 14, 2024 | Date of the 8-K filing. |
Keywords
auditor, accounting, financial statements, WithumSmith+Brown, Moss Adams, audit committee, independent registered public accounting firm
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.